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Abstract
Background: Missing data are common in end-of-life care studies, but there is still relatively little exploration of
which is the best method to deal with them, and, in particular, if the missing at random (MAR) assumption is valid
or missing not at random (MNAR) mechanisms should be assumed. In this paper we investigated this issue through
a sensitivity analysis within the ACTION study, a multicenter cluster randomized controlled trial testing advance care
planning in patients with advanced lung or colorectal cancer.
Methods: Multiple imputation procedures under MAR and MNAR assumptions were implemented. Possible
violation of the MAR assumption was addressed with reference to variables measuring quality of life and
symptoms. The MNAR model assumed that patients with worse health were more likely to have missing
questionnaires, making a distinction between single missing items, which were assumed to satisfy the MAR
assumption, and missing values due to completely missing questionnaire for which a MNAR mechanism was
hypothesized. We explored the sensitivity to possible departures from MAR on gender differences between key
indicators and on simple correlations.
Results: Up to 39% of follow-up data were missing. Results under MAR reflected that missingness was related to
poorer health status. Correlations between variables, although very small, changed according to the imputation
method, as well as the differences in scores by gender, indicating a certain sensitivity of the results to the violation
of the MAR assumption.
Conclusions: The findings confirmed the importance of undertaking this kind of analysis in end-of-life care studies.
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Background
Missing data are common in palliative and end-of-life
care studies, where 20–50% of participants withdraw
early, mostly because of deterioration and/or death [1].
A systematic review and meta-analysis of randomized
controlled palliative intervention trials found about one
quarter of primary endpoint data missing [2]. In the lit-
erature, several methods have been proposed for dealing
with missing data, but there has been relatively little ex-
ploration of which is best in the palliative care setting
[3]. The appropriateness of the chosen method is
strongly related to the nature of the mechanism generat-
ing missing data. Missing data can be categorized as:
missing completely at random (MCAR), when the prob-
ability of an observation being missing does not depend
on both observed and unobserved data; missing at
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random (MAR), when the probability of an observation
being missing depends only on the observed; and miss-
ing not at random (MNAR), when the probability of an
observation being missing also depends on unobserved
data [4].
Complete-case analysis, that consists in performing the
analysis on the subset of subjects with complete informa-
tion, was the most common approach to treat missing
data in randomized clinical trials as recently as 2013 [5, 6].
However, unless the missingness mechanism is MCAR,
this may lead to biased results. When the MCAR assump-
tion is not valid, alternative strategies can be adopted to
deal with missing data: inverse probability weighting,
doubly robust inverse probability weighting, maximum
likelihood estimation, multiple imputation (MI). Among
them, MI is widely recognised as the most appropriate
one in many fields [7]. MI creates several complete ver-
sions of the data by replacing each missing value with
more than one plausible value. Each of the resulting
complete datasets is then analyzed with standard statistical
methods and the results pooled for final inference using
the Rubin’s combination rule, to obtain a point estimate
and a measure of precision which accounts for uncertainty
due to missing information [4, 8]. There are several ways
to implement MI that could be run under MAR and
MNAR [9–12]. One of these is the Multivariate Imput-
ation by Chained Equations (MICE) which relies on the
MAR assumption [9, 10], but can be modified in order to
account for MNAR mechanisms [13].
Missing data in end-of-life care studies can arise due
to the fact that one or more questionnaire items are
missing, or due to the fact that all the questionnaire
items are missing (missing form). While missing items
may be due to simple omissions in questionnaire com-
pilation, reasons for missing a whole questionnaire may
relate to sudden change in the patient’s health status or
to the patient’s sensitivity to specific issues which could
be not adequately measured by the collected variables.
In these cases, the missingness mechanism may be
MNAR [14–18]. Although it is known that performing
MI under the assumption of MAR when the actual miss-
ingness mechanism is MNAR may produce biased esti-
mates [4], this issue is not widely appreciated in dealing
with missing data in palliative care studies [3]. Even if it
is not possible to distinguish between MNAR and MAR
patterns using observed data, the robustness of the MAR
assumption can be investigated through sensitivity ana-
lyses [4, 14]: if the results obtained under MAR and spe-
cific MNAR assumptions are similar, one can conclude
that the presence of unobserved factors does not affect
the conclusions.
The aim of this study was to compare the performance
of different MI methods within the ACTION (Advance
care planning – an innovative palliative care intervention
to improve quality of life in oncology) study by treating
separately missing items and missing questionnaires
[15]. Using a preliminary dataset, we handled the miss-
ing data by applying a MICE procedure under the stand-
ard assumption of MAR and also under MNAR by using
a pattern mixture-model approach, [4, 16] which distin-
guished between missing values due to missing items
and missing the whole questionnaires. We focused on
target analyses to evaluate the sensitivity of the results to
the use of the two procedures.
Methods
Data
The ACTION study is a phase III multicenter cluster
randomised controlled trial, following the CONSORT
guidelines, on the effects of advance care planning
(ACP) in patients with advanced lung or colorectal
cancer. The ACTION Respecting Choices ACP inter-
vention involves trained healthcare professionals who
assist patients and their relatives in reflecting on the
patient’s goals, values and beliefs and in discussing
their healthcare wishes. The intervention has the po-
tential to improve current and future healthcare de-
cision making, provide patients with a sense of
control, and improve quality of life. In total, 22 hos-
pitals in 6 countries were randomised to be interven-
tion or control sites, with up to 1360 patients
participating. At the intervention sites, patients are
offered interviews with a trained ACP facilitator,
whereas in the control sites, patients receive usual
care. All participating patients are asked to complete
questionnaires at baseline, and again after 2.5 and
4.5 months; the questionnaires assess quality of life,
and the extent to which care as received is aligned
with their preferences, their evaluation of decision-
making processes and quality of end-of-life care (see
additional file 2) [15].
Ethical approval was obtained from the Research Eth-
ics Committee (REC) of the coordinating centre (‘Med-
ische Ethische Toetsings Commissie Erasmus MC’), as
well as RECs in all participating countries. The trial was
registered in the International Clinical Trials Registry
Platform (ISRCTN63110516) per 10/3/2014.
Within the ACTION study it was decided to perform a
preliminary analysis on a first subsample of the enrolled
subjects, with the aim to explore methods for dealing
missing data. Our analysis was based on the records of
487 patients, representing the 36% of the final expected
sample, containing information collected through ques-
tionnaires at baseline and at 2.5 months, for a total of 121
variables. Baseline data included personal information
(gender, age, marital status, living with a partner or alone,
living in a private household or in an institution/care facil-
ity, children, years of education, religiosity, ethnic group),
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information on diagnosis (small cell or non-small cell lung
cancer, colon cancer, rectal cancer), cancer stage (III or IV
lung cancer; metachronous metastases or IV colorectal
cancer), WHO performance status (a measure of how well
a person with cancer is able to carry on ordinary daily ac-
tivities), and current treatment (chemotherapy, radiation
therapy, immunotherapy, targeted therapy). Using baseline
and follow-up questionnaires, we calculated scores for
quality of life and symptoms (primary endpoints) and for
shared decision-making, satisfaction with care and coping
with illness (secondary endpoints) (Table 1). All the
scores, except that measuring patient involvement which
was built ad hoc for the present study, are validated and
largely used in the context of psychometrics [17–22]. They
are continuous variables ranging between 0 and 100. Since
an intermediate analysis on the treatment effect was not
planned by protocol, this preliminary analysis was blinded
in respect to treatment arm and country of the partici-
pants, as well as in respect to their survival. Due to the fact
that few patients are expected to die during the first 2.5
months of follow up, for sake of simplicity, in our analysis
we assumed that all patients were still alive at the comple-
tion of the second questionnaire, meaning that no form
was missing because of patient’s death (see discussion).
Statistical methods
In our analysis we first applied the MICE procedure under
MAR assumption. The procedure was applied to all the
variables with missing data, including variables on per-
sonal information, and on diagnosis and treatments. Then
we performed a sensitivity analysis assuming alternative
MNAR mechanisms, within a pattern mixture-model ap-
proach [4, 16]. MI under MNAR required the specification
of additional assumptions on the missingness mechanism
and the modification of the MICE algorithm.
According to the main purpose of the ACTION study,
the sensitivity analysis focused on relevant outcomes of
quality of life and symptoms scores. We estimated
means and 90% confidence intervals of these outcomes
on the overall sample and by gender and their correla-
tions with other scores (i.e. shared decision making, sat-
isfaction with care and coping with illness), under the
different MI approaches. Differences among MI proce-
dures were evaluated by comparing point estimates and
their confidence intervals in a descriptive way. If, under
all the MNAR models, the direction of the explored rela-
tionships was the same as that under MAR and the con-
fidence intervals largely overlapped, we concluded that
the results were robust to violation of the MAR assump-
tion. Due to the fact that at this stage of the analysis we
are not interested in performing statistical tests, but only
in describing the results, we preferred to report the 90%
confidence intervals instead of the 95% ones in order to
discourage their use as a surrogate of p-value = 0.05 [23].
Multiple imputation by chained equations under MAR
assumption
Let Y = (Y1,…,YJ) be the n⨯J matrix of the data, where Yj =
(y1j, y2j,…ynj)
T is the vector of length n representing the
values assumed by the jth variable in the n subjects. Let R=
(R1,…, RJ) be a n⨯J matrix, with Rj = (r1j, r2j, …,rnj)T vector of
the missingness indicators for the jth variable (rij= 0 if yij is
missing and rij = 1 otherwise). Let us denote the observed
entries and the missing entries of Y as Yobs and Ymis, re-
spectively. Analogously, let Yj obs and Yj mis be the observed
and the missing entries of the vector Yj. Under the MAR
Table 1 Primary and secondary endpoints (scales) measured with questionnaires at baseline and follow-up
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assumption of conditional independence between Ymis and
R given the observed data Yobs, ƒ(Ymis|Yobs, R) = ƒ (Ymi-
s|Yobs), the MICE algorithm required the specification of the
univariate conditional distributions f(Yj|Y-j, θj) in the form of
regression models for the variables with missing values,
where Y-j = (Y1, …, Yj-1, Yj + 1, …, YJ) and θj was a vector of
unknown regression parameters [9]. In our analysis, in order
to avoid collinearity and related computational problems, as-
suring at the same time good prediction, a preliminary selec-
tion of the predictors to be included in the regressions was
performed (in practice some of the elements of θj have been
set to zero). In particular, we regressed each variable Yj with
missing entries on each of the other variables, completed by
a preliminary imputation which draw from their empirical
marginal distribution. Then, we calculated the Akaike’s in-
formation criterion (AIC) for each regression and selected
as predictors for Yj the 15 variables which lead to the smal-
lest AIC values [24]. Considering the number of observa-
tions and the large percentage of missing values in most of
the follow up scores, 15 was considered an appropriate
number of covariates [10]. The marginal regressions used in
this preliminary procedure and in the following imputation
algorithms varied according to the nature of the outcome
variable (linear regression for continuous variables, logistic
regression for factor variables with 2 levels, multinomial lo-
gistic regression for factor variables with more than 2 levels,
and proportional odds models for ordered variables). Finally,
for each incomplete variable, the set of the selected predic-
tors was enriched by including the indicators of gender, age,
type of cancer and WHO performance status. The selected
predictors for each incomplete variable are reported in Fig-
ure A1 of the additional file 1.
Once defined the conditional distributions f(Yj|Y-j, θj)
and assumed non-informative priors on θj, the MICE al-
gorithm consisted in the following steps. First, we ran-
domly drew an initial imputation Ŷ 1;…; Ŷ J for the
missing values in Ymis, by sampling from the empirical
marginal distributions of the variables with missing entries
(step 0). Then, for the first variable Yj with missing entries:
1 we sampled θ̂ j from the posterior distribution f ðθ jj
Y j obs; Ŷ − jÞ,
2 we drew Ŷ j mis from the posterior predictive
distribution f ðY jjY j obs; Ŷ − j; θ̂ jÞ.
We repeated steps 1 and 2 sequentially for each vari-
able with missing entries in the dataset, and we repeated
the entire procedure, excluding step 0, until algorithm
convergence (100 iterations) [25]. At the end, we got a
complete dataset. We created several complete versions
of the data by repeating the procedure M times, choos-
ing M according to the rule of thumb based on the aver-
age percentage rate of missingness [26].
The MICE procedure was implemented by using the
mice library of the R software [27, 28].
Multiple imputation by chained equations under MNAR
assumption
Let us suppose that the MAR assumption is not valid.
This, in general, implies that the posterior predictive dis-
tribution of Yj mis at step 2 of the MICE algorithm de-
pends on R. In order to account for this dependency,
according to the pattern mixture-model approach [4,
16], the MICE algorithm can be modified defining dis-
tinct posterior predictive distributions depending on the
missing data patterns in R. For example, let us assume
that we are in the simple case in which the value of Yj
mis depends on the observed and on the fact that Yj is
missing, but not on the fact that other variables are
missing. In this case, we would have two distinct poster-
ior predictive distributions, one for Rj = 0 and one for
Rj = 1:
f ðY jjY j obs; Ŷ − j; θ̂ jR j¼0Þ and f ðY jjY j obs; Ŷ − j; θ̂ jR j¼1Þ,
and the step 2 of the MICE algorithm can be modified
as follows. After having sampled θ̂ j
R j¼1
from the poster-
ior distribution f ðθ jjY j obs; Ŷ − jÞ , we generate θ̂ jR j¼0
from the conditional distribution f ðθR j¼0j jŶ − j; θ̂
R j¼1
j Þ , a
priori defined according to an assumed hypothesis on
the MNAR mechanism. Finally, we sample Ŷ j mis from
the posterior predictive distribution f ðY jjY j obs; Ŷ − j;
θ̂ j
R j¼0Þ . More in general, when the value of Yj mis de-
pends also on the fact that other variables are missing,
there are in principle distinct predictive distributions for
each pattern of missing data [29].
Partition of the missing values and modified MICE in the
ACTION study
In our analysis, we explored the violation of the MAR
assumption, making a distinction between missing items
due to the fact that the patient did not reply to some
items in a questionnaire and missing items due to the
fact that the form was completely missing (this could
happen for the second questionnaire, but not for the
baseline one), for which a violation of the MAR assump-
tion could be hypothesised. In particular, we introduced
two matrices of missingness indicators, RI which indi-
cated the missing values of the first type and RF which
indicated the missing values of the second type. The two
matrices described a partition of the missing values; for
simplicity we called MI the first element of the partition
(collection of the missing data defined by RI) and MF
(collection of missing data defined by RF). Then, we as-
sumed a possible MNAR mechanism for the missing
values in MF:
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f ðYmisjYobs;RI;RFÞ ¼ f ðYmisjYobs;RFÞ;
with ƒ (Ymis|Yobs, R
F) possibly different from ƒ
(Ymis|Yobs).
Two distinct posterior predictive distributions were
defined for each Yj with missing values in M
F, one for
RFj = 0 and one for R
F
j = 1:
f ðY jjY jobs; Ŷ − j; θ̂ jR
F
j ¼0Þ and f ðY jjY jobs; Ŷ − j; θ̂ jR
F
j ¼1Þ:
The described violation of the MAR assumption re-
quired a modification of the MICE algorithm that relied
on a model for f ðθR
F
j ¼0
j jŶ − j; θ̂
RFj ¼1
j Þ . The modified
MICE algorithm that we implemented for our analysis
was the following. After having randomly drawn an ini-
tial imputation Ŷ 1;…; Ŷ J for the missing values by sam-
pling from the empirical marginal distributions of the
variables with missing entries (step 0), we imputed the
missing values for the first variable Yj with missing en-
tries, according to the following steps:
1 we sampled θ̂ j from the posterior distribution f ðθ jj
Y j obs; Ŷ − jÞ,
2 we drew Ŷ j mis from the posterior predictive
distribution f ðY jjY j obs; Ŷ − j; θ̂ jÞ,
3 if Yj had missing entries in M
F, we generated θ̂
RFj ¼0
j
from the conditional distribution f ðθR
F
j ¼0
j jŶ − j;
θ̂
R Fj ¼1
j Þ, a priori defined according to our hypothesis
on the MNAR mechanism (see below), and we
sampled Ŷ j mis from the posterior predictive




We repeated step 1-step 3 for all variables with missing
entries sequentially, until algorithm convergence (100 it-
erations). We repeated the whole procedure M times in
order to create M complete versions of the data set. In
running the algorithm, we ordered the variables accord-
ing the number of missing values (from the variable with
fewer missing entries to that one with more missing
entries).
Assumptions on the MNAR mechanism
We assumed that the MAR assumption was violated
with reference to the six primary endpoints expressing
the patient’s health status, as measured by the second
questionnaire: follow-up scores pain (PA), dyspnoea
(DY), emotional functioning (EF), physical functioning
(PF), fatigue (FA) and quality of life (QOL). Under the
general assumption that reasons for missing the second
questionnaire as a whole may relate to sudden changes
in the patient’s health status or to sensitivity to specific
issues not adequately measured by the other variables [4,
14, 30–33], patients with a poorer health status were
those for whom we expected to have larger probability
of missing form. Our definition of the MNAR mecha-
nisms reflected these hypotheses.
Even if in principle the model for f ðθR
F
j ¼0
j jŶ − j; θ̂
RFj ¼1
j Þ
could be highly complex, we specified two simple alter-
native models [13, 34, 35]. The first model assumed a
constant shift k in the expected value of each of the six
variables between observed and missing observations be-
longing to MF. We considered four different shifts k1, …,
k4 defined as the equispaced values between 0 and ½
interquartile range of the variable. The second model
allowed the shift k to vary among individuals according
to their WHO performance status. Let YWHO be the vari-
able expressing the WHO performance status, and sd(Yj
obs) the standard error for one of the six primary end-
points, calculated on the observed values; the shift k was
defined as k = YWHO⨯sd(Yjobs)/4. The shift was always as-
sumed to be in the direction of worsening the patient’s
health conditions (subtracted for QOL, PF, EF and
added for the other scores).
Analysis of data
We implemented the algorithm for the MNAR model by
modifying the existing mice function of the mice R li-
brary. We used the passive imputation built-in method
in order to incorporate at each step of the imputation al-
gorithm the transformations required by the MNAR as-
sumptions [27, 28, 34].
At the end of the MI procedure (MICE or modified
MICE), each of the M complete datasets was analysed
applying standard statistical methods and the results
were combined according to the Rubin’s rules [4]. Indi-
cating with Q the unknown parameter of interest, for ex-
ample the average quality of life score, let Q̂m be the
point estimate of Q and Ûm the estimate of its variance,
arising from the analysis on the mth dataset (m = 1, …,




M and its estimated variance was T =U+(1 + 1/M) B,








ðM − 1Þ :
Results
In Tables 2 and 3, we report descriptive statistics and
percentage of missing values for socio-demographic,
diagnosis and treatment variables measured at baseline,
and for baseline and follow-up scores of quality of life
and symptoms, shared decision-making, satisfaction with
care and coping with illness. Between 1 and 15% of
socio-demographic data, clinical data and baseline scores
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were missing. Missing values at follow-up were around
36–39%, mostly due to missing forms (170/487; 35%).
In the additional file 1, we reported the missing data
pattern (figure A1), as well as the selected predictors for
each univariate conditional regression used in the imput-
ation procedures (figure A2).
Table 4 shows means and 90% confidence intervals of
quality of life scores and symptoms at follow up, calcu-
lated from the observed data and after MI under MAR
and MNAR assumptions setting M = 40, which approxi-
mately corresponded to the maximum percentage rate
of missingness [26]. When compared with the values cal-
culated on the observed data, the results under MAR
suggested that missingness was related to poor health
status and lower quality of life, with the means after
MICE moving in the direction of a worse health, i.e. de-
creasing for QOL, PF, EF and increasing for PA, DY and
FA. Assuming MNAR mechanisms the discrepancy be-
tween imputed values and observed values was markedly
greater.
Table 5 shows the mean scores by gender, calculated
on the observed, under the MAR model and under the
MNAR model that assumed a degree of departure from
MAR dependent on the WHO performance status.
Under both imputation approaches, there was a clear
difference between genders, with males reporting a bet-
ter health state than females. The size of the difference
between genders increased under the MNAR model.
All correlations of secondary endpoints (patient in-
volvement, overall quality of care, active coping, denial)
with primary endpoints related to symptoms (FA, PA,
DY) were negative, whereas those with primary end-
points related to functioning (QOL, PF, EF) were posi-
tive, although very low. As an example, in Fig. 1 we
show the correlation coefficients between QOL and the
four selected secondary endpoints. Overall quality of
care showed the higher correlations with primary end-
points. Although in general correlations after MICE
were robust to violations of the MAR assumption, some-
times a certain discrepancy was observed between the
different imputation methods (see additional file 1 Fig-
ures A3-A7). In particular, under the MNAR scenarios
all correlations involving denial were weaker than under
MAR. A similar behaviour was observed also for patient
involvement.
Discussion
Reviews of randomized controlled trials indicate wide
variation in how missing data are dealt with. Relatively
few studies use MI (8%), and, when carried out, it is
mainly under MAR assumption; few studies assume
MNAR mechanisms [5, 6, 36]. As usual in end-of-life
care studies, the proportion of missing values in the sub-
set of the ACTION study data analysed in the present
paper was high, particularly in relation to quality of life
and symptoms outcomes. The percentage of missing
forms at follow up was around 37%, thus higher than
the 23% reported in a recent meta-analysis of random-
ized controlled trials on palliative interventions [2].
Although the availability of many variables should
make the MAR assumption reasonable, quality of life is
a multidimensional and complex concept and it is diffi-
cult to exclude the presence of relevant unmeasured fac-
tors, particularly in end of life care studies where
reasons for missing values may relate to the patient’s
health status or their sensitivity to specific issues [14,
30–33]. Because the violation of the MAR assumption
can significantly affect final results, particularly when the
proportion of missing values is high, we performed a
sensitivity analysis to evaluate if the results obtained as-
suming MAR were robust to the presence of MNAR. In
particular, we focused on means and correlations be-
tween primary and secondary outcomes or between pri-
mary outcomes and individual characteristics (gender).
Performing MI under both MAR and MNAR assump-
tions produced different estimates of the average score
of the primary outcomes. The results under MAR sug-
gested that missingness was related to poor health status
and lower quality of life. This is consistent with the
common sense idea that more critical patients could
have greater problems in filling questionnaires. As ex-
pected, assuming MNAR mechanisms which explicitly
assigned higher probabilities of missing form to those
patients who experienced worse health status, the dis-
crepancy between imputed values and observed values
became markedly greater. Males showed a better health
than females. After imputation, the difference became
even more marked, particularly under the MNAR
models. The marginal correlations between primary and
secondary endpoints were consistently negative for
symptoms and positive for functioning and quality of
life. As an example, quality of life was positively associ-
ated with patient involvement, overall quality of care, ac-
tive coping and denial. On the contrary, pain was
negatively correlated with the same variables. In agree-
ment with clinical expectations, overall quality of care
had the strongest correlations with the primary out-
comes. The correlations of the primary outcomes with
denial appeared to be weaker under the MNAR scenar-
ios than when assuming MAR. These findings suggest
that the provisional indicators which we focused on in
the present analysis were not always robust to violation
of the MAR assumption.
The peculiar features of our approach are mainly two.
First, we integrated the MNAR model within the MICE
algorithm as implemented in the mice function through
the passive imputation built-in method [34], so that im-
putation error was correctly propagated [37]. This is
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different from following a two-step procedure that first
imputes each outcome under the MAR assumption, and
then modifies the imputed values according to a specific
model for MNAR [13, 31, 33, 38, 39]. Additionally, our
algorithm accounts for the different nature of the
missing values in the data set: missing entries satisfying
the MAR assumption (15.3% of the total number of
missing values) and missing entries, due to missing form,
for which a MNAR mechanism could be hypothesised
(84.7%).
Table 2 Descriptive statistics on personal information and diagnosis information at baseline
Personal information
Age Live with a partner, n (%) Religious, n(%)











missing 4 (0.82) Living place, n (%) prefer not to specify 64 (13.14)
male 292
(59.96)






Marital status, n (%) institution/care facility 3 (0.62) yes 7 (1.44)




Children, n (%) Years of education
unmarried 41 (8.42) missing 8 (1.64) missing, n (%) 73 (14.99)








WHO performance status, n (%) Stage of cancer, n (%)
missing 4 (0.82) missing 5 (1.03) missing 7 (1.44)
small cell lung 62 (12.73) 0 fully active 167
(34.29)
III lung 59 (12.11)
non-small cell lung 218
(44.76)






2 symptomatic, < 50% in bed during the day 58 (11.91) IV colorectal 134
(27.52)
rectal 48 (9.86) 3 symptomatic, > 50% in bed, but not
bedbound




Chemotherapy, n (%) Immunotherapy, n (%)










Targeted therapy, n (%)





yes 38 (7.80) yes 59 (12.11)
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In the literature, several algorithms have been pro-
posed that modify MICE accounting for the violation of
the MAR assumption [13, 29, 34, 35, 38]. Recently,
Tompsett and colleagues [29] proposed an approach,
called Not-At-Random Fully Conditional Specification
(NARFCS), which generalizes the MICE algorithm to
MNAR, by including in each univariate conditional re-
gression model the missingness indicator of the variable
to be imputed (the coefficient of which cannot be esti-
mated from the data and is the object of the sensitivity
analysis), as well as the missingness indicators of the
other incomplete variables. In this way, it is possible to
allow for the presence of correlations between each vari-
able and the missingness indicators of the others. Unlike
NARFCS, our approach assumed that these correlations
were equal to zero, because it included a missing form
indicator only in the univariate conditional models used
for the imputation of quality of life and symptoms scores
(i.e. the variable interested by MNAR). However, in a
sensitivity analysis, we included the missing form
Table 3 Means of the scores (calculated using observed data) at baseline and at 2.5 months of follow-up (sd: standard deviation)
Variable Baseline Follow-up
mean (sd) missing (%) mean (sd) missing (%)
Pain 21.41 (24.03) 6 (1.23) 20.67 (25.16) 175 (35.93)
Dyspnoea 25.28 (28.08) 7 (1.44) 26.33 (27.83) 173 (35.52)
Insomnia 27.36 (28.03) 7 (1.44) 25.27 (26.35) 173 (35.52)
Appetite loss 21.14 (29.95) 6(1.23) 21.87 (29.24) 173 (35.52)
Constipation 19.72 (29.14) 7(1.44) 18.33 (26.84) 176 (36.14)
Emotional functioning 78.41 (20.50) 11(2.26) 79.84 (21.22) 179(36.76)
Physical functioning 69.58 (23.91) 9 (1.85) 68.69 (25.60) 177 (36.34)
Fatigue 41.66 (26.22) 9 (1.85) 41.68 (25.70) 174 (35.73)
Nausea and vomiting 11.54 (20.42) 6 (1.23) 11.52 (22.39) 173 (35.52)
Quality of life 65.05 (20.27) 13 (2.67) 64.16 (21.84) 174 (35.73)
Decision making participation self-efficacy 75.06 (23.77) 17 (3.49) 76.53 (22.59) 179 (36.76)
Patient involvement 74.71 (18.24) 19 (3.90) 75.80 (18.30) 181 (37.17)
Doctors information provision 72.37 (23.74) 8 (1.64) 70.67 (24.41) 181 (37.17)
Nurses information provision 71.82 (24.29) 21(4.31) 70.05 (23.99) 191 (39.22)
Overall quality of care 76.21 (21.48) 12 (2.46) 73.03 (22.16) 183 (37.58)
Active coping 71.34 (25.49) 20(4.11) 68.26(27.40) 184 (37.78)
Planning 66.35 (27.97) 17 (3.49) 66.17 (27.92) 185 (37.99)
Acceptance 74.34 (21.70) 21 (4.31) 73.58 (22.34) 182(37.37)
Denial 23.20 (27.04) 25 (5.13) 20.68(25.37) 186 (38.19)
Table 4 Mean (90% confidence interval) of the scores at 2.5 months of follow-up up (Quality of life; Pain; Dyspnoea; Emotional
functioning; Physical functioning; Fatigue) observed and imputed under the MAR assumption and using different models for
departure from MAR (kWHO; k1; k2; k3; k4)
Variable observed MAR kWHO k1 k2 k3 k4
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indicator in each univariate conditional distribution, thus
allowing for the possible correlation between having a
missing form and all the variables in the data set. The
results of this sensitivity analysis were very similar to
those reported in the paper (see additional file 1 Tables
A1-A2).
Recently, imputation algorithms based on nonlinear
models, such as classification and regression trees or
random forests, have spread. These approaches allow to
deal with complex interactions and nonlinearities in the
prediction models. Additionally, they do not require pre-
selection of predictors and can be used also when the
number of covariates is larger than the number of obser-
vations [40, 41]. However, the performance of these
methods is not well stated. It depends on the presence
and relevance of possible interaction effects and on the
correlation structure of the data, and it could be quite
poor when data are highly skewed [42–44]. It would be
interesting to investigate the robustness to departure
from the MAR assumption for multiple imputations ap-
proaches based on recursive partitioning. However, at
the best of our knowledge, there are no studies dealing
with such algorithms under the MNAR assumption and
extending the pattern-mixture model to this context de-
serves ad hoc investigation.
Limitations
We fixed the number of imputations to 40 following a
rule proposed by White and colleagues [26]. Since in this
preliminary analysis we focused on different quantities,
all surrogate in respect to the primary endpoint of the
ACTION study, we did not perform a detailed investiga-
tion in order to determine an optimal number of impu-
tations, which in principle should be based on the
Fraction of Missing Information evaluated for the par-
ameter of interest [26] or on criteria aimed to assure re-
sults stability over repetitions of the MI procedure [45].
The present results could be sensitive to the prediction
models specification. Models with a larger number of
predictors or with predictors selected with different
methods (e.g. LASSO) or models which includes interac-
tions could result more or less robust to violation of the
MAR assumption, leading to different conclusions. This
point will be addressed when the mixed-pattern ap-
proach proposed in this paper will be applied on the
complete ACTION data set. As one of the main limita-
tions of the present study, we would like to remark that
we did not account for the cluster randomized design of
the study, because information on treatment assignment
and cluster variables (country and hospitals) was blinded
to us [46, 47]. Similarly, also patient’s survival at follow
up was not available, so that we had no information
about possible truncation by death. At this stage of the
study, truncation by death was likely a minor problem
since the analyses have been carried out with a follow-
up of 2.5 months from recruitment and most of the en-
rolled patients had a good WHO performance status at
baseline (the median survival for both small and non-
small cell lung cancer in both stage III and IV is esti-
mated to be around 7–8months [48, 49], and 2.6 and
1.7 years for patients with and without metastasectomy,
respectively [50]). Truncation by death is however a very
relevant point that should be address in the future in
order to get reliable estimates of the treatment effect
[51–54]. Moreover, the MI on the complete ACTION
dataset will be performed separately by treatment arm
[46].
Conclusions
In imputing missing data in end-of-life care studies, sen-
sitivity analyses for the departure from MAR should be
performed. We proposed a modification of the MICE al-
gorithm which accounts for the presence in the data set
of two kind of missing data: missing entries satisfying
the MAR assumption and missing entries, due to miss-
ing form, for which a MNAR mechanism could be
hypothesised. We found that the results obtained after
having imputed the missing values through MICE were
not always robust to possible violations of the MAR
assumption.
Table 5 Mean (90% confidence interval) of the scores at 2.5 months of follow-up (Quality of life; Pain; Dyspnoea; Emotional
functioning; Physical functioning; Fatigue) for males and females observed and imputed under the MAR assumption and under the
MNAR model assuming a shift depending on the WHO score (kWHO)
observed MAR kWHO
Variable males females males females males Females
Quality of life 66.67 (66.60,66.74) 60.06 (59.98,60.13) 65.69 (65.62,65.76) 58.94 (58.87,59.02) 61.32 (61.25,61.39) 55.01 (54.93,55.08)
Pain 19.22 (19.15,19.30) 22.92 (22.82,23.01) 20.71 (20.62,20.80) 24.90 (24.82,24.99) 26.01 (25.91,26.10) 31.12 (31.01,31.24)
Dyspnoea 25.04 (24.95,25.14) 28.69 (28.59,28.79) 25.75 (25.66,25.84) 29.00 (28.90,29.09) 35.34 (35.24,35.44) 39.50 (39.36,39.64)
Emotional functioning 83.96 (84.02,83.90) 73.02 (73.10,72.94) 82.88 (82.81,82.95) 72.11 (72.04,72.19) 78.64 (78.57,78.71) 65.80 (65.70,65.89)
Physical functioning 69.86 (69.77,69.95) 66.50 (66.41,66.58) 68.82 (68.74,68.90) 64.83 (64.74,64.93) 63.90 (63.82,63.98) 59.99 (59.90,60.09)
Fatigue 39.09 (39.01,39.18) 46.19 (46.10,46.28) 40.14 (40.05,40.22) 47.12 (47.04,47.21) 46.54 (46.45,46.63) 54.33 (54.22,54.43)
Carreras et al. BMC Medical Research Methodology           (2021) 21:13 Page 9 of 12
Fig. 1 Correlations (90% confidence intervals) between Quality of life and secondary endpoints (Patient involvement; Overall quality of care;
Active coping; Denial) calculated after MI under the MAR assumption and under different MNAR models (kWHO; k1; k2; k3; k4)
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